Finance

Lists
Why is ACET up 9.07%?
Dive Deeper
ACET:NASDAQ
Adicet Bio Inc
$9.02
+9.07%
(+0.75) 1D
$9.90
+9.76% (+0.88)
After hours
Closed: Sep 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACET...
Open
$8.29
High
$9.11
Low
$8.29
Mkt. cap
84.44M
Avg. vol.
129.08K
Volume
638.60K
52-wk high
$17.44
52-wk low
$6.01
EPS
-$13.02
Beta
1.58
Shares outstanding
9.36M
No. of employees
102
Open
$8.29
High
$9.11
Low
$8.29
Mkt. cap
84.44M
Avg. vol.
129.08K
Volume
638.60K
52-wk high
$17.44
52-wk low
$6.01
EPS
-$13.02
Beta
1.58
Shares outstanding
9.36M
No. of employees
102
News stories
From web sources and news partners
About Adicet Bio Inc
CEO-
Employees102
Founded2014
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteadicetbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ACET in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ACET in the last 3 months.
Highest
Current $9.02
$27.00 (+199.33%)
Average
$22.50 (+149.45%)
Lowest
$18.00 (+99.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
$18.00
+99.6%
09/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$27.00
+199.3%
09/21/2026
Boris Peaker
JonesTrading
Buy
Maintained
$20.00
+121.7%
09/01/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$25.00
+177.2%
08/06/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$25.00
+177.2%
08/06/2026
Anthea Li
Jefferies
Buy
Initiated
$19.00
+110.6%
05/04/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+121.7%
04/06/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
-
-
03/16/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$100.00
+1,008.6%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.85M
25.04M
17.49M
18.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.10M
6.85M
4.08M
3.85M
Operating expense
27.95M
31.89M
21.57M
22.30M
Total operating expenses
27.95M
31.89M
21.57M
22.30M
Operating income
-27.95M
-31.89M
-21.57M
-22.30M
Other non operating income
-64.00K
-130.00K
7.00K
-60.00K
EBT including unusual items
-26.86M
-30.52M
-20.24M
-21.22M
EBT excluding unusual items
-26.86M
-30.52M
-20.24M
-21.22M
Income tax expense
-
-
-
143.00K
Effective tax rate
-
-
-
-0.67%
Other operating expenses
-
-
-
-
Net income
-26.86M
-30.52M
-20.24M
-21.36M
Net profit margin
-
-
-
-
Earnings per share
-4.64
-2.94
-1.88
-1.99
Interest and investment income
1.17M
1.52M
1.34M
1.17M
Interest expense
-12.00K
-24.00K
-23.00K
-22.00K
Net interest expenses
1.16M
1.50M
1.32M
1.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.38M
-30.41M
-20.23M
-21.10M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps